What is the address of K&T Medical?

The registered office of K&T Medical is located at Rue Mont du Berger 11, 6041 Charleroi.

Is K&T Medical still active?

Yes. According to the CBE (1 October 2026) K&T Medical is active, legal situation “Normale toestand”, started on 14 July 2015.

Is K&T Medical registered on Peppol?

No, K&T Medical is currently not registered on the Peppol network.

What is the enterprise number of K&T Medical?

The enterprise number of K&T Medical is BE0633806908.

When was K&T Medical founded?

K&T Medical was founded on 14 July 2015.

Is K&T Medical a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 July 2015; 4 annual accounts filed, latest fiscal year 2024.

How much profit did K&T Medical make in 2024?

K&T Medical posted a profit after taxes of € 254,242 in financial year 2024.

What is the revenue of K&T Medical?

As a small company, K&T Medical is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 402,523.

K&T Medical (Private Limited) - Charleroi - BE0633806908

Dossier K&T Medical, printed on 1 October 2026 from databakkes.be/en/0633806908/k-t-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

K&T Medical from Charleroi, company number BE0633806908, closed financial year 2024 with a result of € 254,242 after tax. For that financial year K&T Medical recorded a gross margin of € 402,523 and equity of € 861,152. Compared with financial year 2023, the result moved from € 151,565 to € 254,242. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 28, 2025.

What it is worth Growing

€ 861,152

▲ 42% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 254,242

▲ 68% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 573,730

▲ 62% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 711,430.

People and assets in 2024

Vehicles and equipment

€ 67,684

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 82,959

▲ 180% vs 2023

€ 17,008 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 7,790

▲ 5% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 83,826

▼ 10% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 159,833 Gross margin 2021: € 159,833 First fiscal year in the series	€ 222,668 Gross margin 2022: € 222,668 ▲ 39% vs 2021 (€ 159,833) Favourable step	€ 254,199 Gross margin 2023: € 254,199 ▲ 14% vs 2022 (€ 222,668) Favourable step	€ 402,523 Gross margin 2024: € 402,523 ▲ 58% vs 2023 (€ 254,199) Favourable step	▲ 58%
Profit after taxes	€ 105,913 Profit after taxes 2021: € 105,913 First fiscal year in the series	€ 125,762 Profit after taxes 2022: € 125,762 ▲ 19% vs 2021 (€ 105,913) Favourable step	€ 151,565 Profit after taxes 2023: € 151,565 ▲ 21% vs 2022 (€ 125,762) Favourable step	€ 254,242 Profit after taxes 2024: € 254,242 ▲ 68% vs 2023 (€ 151,565) Favourable step	▲ 68%
Equity	€ 329,582 Equity 2021: € 329,582 First fiscal year in the series	€ 455,344 Equity 2022: € 455,344 ▲ 38% vs 2021 (€ 329,582) Favourable step	€ 606,910 Equity 2023: € 606,910 ▲ 33% vs 2022 (€ 455,344) Favourable step	€ 861,152 Equity 2024: € 861,152 ▲ 42% vs 2023 (€ 606,910) Favourable step	▲ 42%
Total debts	€ 84,508 Total debts 2021: € 84,508 First fiscal year in the series	€ 143,219 Total debts 2022: € 143,219 ▲ 69% vs 2021 (€ 84,508) Unfavourable step	€ 160,823 Total debts 2023: € 160,823 ▲ 12% vs 2022 (€ 143,219) Unfavourable step	€ 202,505 Total debts 2024: € 202,505 ▲ 26% vs 2023 (€ 160,823) Unfavourable step	▲ 26%
Cash	€ 326,542 Cash 2021: € 326,542 First fiscal year in the series	€ 257,444 Cash 2022: € 257,444 ▼ 21% vs 2021 (€ 326,542) Unfavourable step	€ 354,151 Cash 2023: € 354,151 ▲ 38% vs 2022 (€ 257,444) Favourable step	€ 573,730 Cash 2024: € 573,730 ▲ 62% vs 2023 (€ 354,151) Favourable step	▲ 62%
Land & buildings	-	€ 146,933 Land & buildings 2022: € 146,933 First fiscal year in the series	€ 134,024 Land & buildings 2023: € 134,024 ▼ 9% vs 2022 (€ 146,933) Unchanged	€ 315,246 Land & buildings 2024: € 315,246 ▲ 135% vs 2023 (€ 134,024) Unchanged	▲ 135%
Retained profit	€ 327,082 Retained profit 2021: € 327,082 First fiscal year in the series	€ 452,844 Retained profit 2022: € 452,844 ▲ 38% vs 2021 (€ 327,082) Favourable step	€ 604,410 Retained profit 2023: € 604,410 ▲ 33% vs 2022 (€ 452,844) Favourable step	€ 711,430 Retained profit 2024: € 711,430 ▲ 18% vs 2023 (€ 604,410) Favourable step	▲ 18%
Bank debt	€ 68,067 Bank debt 2021: € 68,067 First fiscal year in the series	€ 42,149 Bank debt 2022: € 42,149 ▼ 38% vs 2021 (€ 68,067) Favourable step	€ 29,637 Bank debt 2023: € 29,637 ▼ 30% vs 2022 (€ 42,149) Favourable step	€ 82,959 Bank debt 2024: € 82,959 ▲ 180% vs 2023 (€ 29,637) Unfavourable step	▲ 180%
Balance sheet total	€ 414,090 Balance sheet total 2021: € 414,090 First fiscal year in the series	€ 598,563 Balance sheet total 2022: € 598,563 ▲ 45% vs 2021 (€ 414,090) Unchanged	€ 767,733 Balance sheet total 2023: € 767,733 ▲ 28% vs 2022 (€ 598,563) Unchanged	€ 1,063,656 Balance sheet total 2024: € 1,063,656 ▲ 39% vs 2023 (€ 767,733) Unchanged	▲ 39%

Key figures of K&T Medical, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to K&T Medical?

What happened at K&T Medical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 28, 2025 New annual accounts for financial year 2024: profit of € 254,242 (▲ 68% vs 2023). filed late Source: NBB ↗
Jul 14, 2015 New establishment in Charleroi. KBO
Jul 14, 2015 Start of the company according to the CBE. KBO

In short

From € 105,913 profit in 2021 to € 254,242 profit in 2024.

Paid € 258,992 in corporate taxes since 2021.

Best year ever: 2024, with € 254,242 profit.

Original PDFs at the National Bank ↗

A new publication or filing at K&T Medical? We notify you, reason included.

Follow K&T Medical

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Mont du Berger 11

6041 Charleroi

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

KWZ & Partners

€ 9,469 gross margin · 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0633.806.908
VAT number: BE 0633.806.908
Registered office: Rue Mont du Berger 11, 6041 Charleroi
Names & denominations: K&T Medical
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 July 2015
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

K&T Medical